IL6 and metabolic syndrome: Emerging studies reveal that MetS-associated genetic variants disrupt adipokine signaling, thereby promoting systemic insulin resistance and pro-inflammatory cytokine release (e.g., TNF-α, IL-6), which synergistically aggravate myocardial inflammation during reperfusion (11).